These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. HIV therapy and diabetes risk. Dagogo-Jack S Diabetes Care; 2008 Jun; 31(6):1267-8. PubMed ID: 18509145 [No Abstract] [Full Text] [Related]
9. [Antiretroviral therapy with nelfinavir for patient infected, by HIV and secondary diabetes mellitus due to indinavir]. Pedrol Clotet E; Rodellar Oncins MT; Soler Sendra A; MartÃnez Losada EJ Med Clin (Barc); 2002 Sep; 119(10):398-9. PubMed ID: 12372178 [No Abstract] [Full Text] [Related]
10. Diabetes mellitus in HIV-infected women. Nagy GS AIDS Clin Care; 2003 May; 15(5):44-5. PubMed ID: 12793350 [No Abstract] [Full Text] [Related]
12. Protease inhibitor-associated diabetes mellitus: a potential cause of morbidity and mortality. Fantry LE J Acquir Immune Defic Syndr; 2003 Mar; 32(3):243-4. PubMed ID: 12626882 [No Abstract] [Full Text] [Related]
13. Health advisory: high blood sugar and diabetes seen in protease inhibitor users. Crit Path AIDS Proj; 1998; (No 33):31-2. PubMed ID: 11366367 [TBL] [Abstract][Full Text] [Related]
14. Protease inhibitors may raise blood glucose levels, FDA warns. Am J Health Syst Pharm; 1997 Jul; 54(14):1575. PubMed ID: 9248598 [No Abstract] [Full Text] [Related]
15. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. Carr A; Samaras K; Burton S; Law M; Freund J; Chisholm DJ; Cooper DA AIDS; 1998 May; 12(7):F51-8. PubMed ID: 9619798 [TBL] [Abstract][Full Text] [Related]
16. Protease inhibitors: FDA warns doctors of diabetes risk. Food and Drug Administration. AIDS Treat News; 1997 Jun; (No 273):5-6. PubMed ID: 11364400 [TBL] [Abstract][Full Text] [Related]
17. Trends in rates of myocardial infarction among patients with HIV. Holmberg SD; Moorman AC; Greenberg AE N Engl J Med; 2004 Feb; 350(7):730-2; author reply 730-2. PubMed ID: 14960752 [No Abstract] [Full Text] [Related]
18. AACTG recommendations for metabolic problems. Guide covers insulin resistance and diabetes. AIDS Alert; 2003 Jan; 18(1):6. PubMed ID: 12541993 [TBL] [Abstract][Full Text] [Related]
19. [Diabetes and hyperglycemia in patients under treatment for HIV infection with the protease inhibitors indavir, ritonavir, saquinavir as well as nelfinavir (in development, but not yet released]. Pharm Unserer Zeit; 1997 Dec; 26(6):317. PubMed ID: 9513575 [No Abstract] [Full Text] [Related]
20. Effects of metformin on insulin resistance and central adiposity in patients receiving effective protease inhibitor therapy. Saint-Marc T; Touraine JL AIDS; 1999 May; 13(8):1000-2. PubMed ID: 10371188 [No Abstract] [Full Text] [Related] [Next] [New Search]